Azar vows to lower list prices

HHS Secretary nominee Alex Azar Tuesday rejected government negotiation of Medicare Part D drug prices and signaled his support for reforming the way Part B reimburses for infused and injected drugs. Speaking at a Senate Finance Committee confirmation hearing, Azar said lowering drug prices will be his

Read the full 470 word article

User Sign In